Investing.com - GlycoMimetics (NASDAQ: GLYC) reported third quarter EPS of $-0.140, in line with the analyst estimate of $-0.140. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
GlycoMimetics's stock price closed at $1.290. It is down -20.860% in the last 3 months and up 101.790% in the last 12 months.
GlycoMimetics saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See GlycoMimetics's stock price’s past reactions to earnings here.
According to InvestingPro, GlycoMimetics's Financial Health score is "fair performance".
Check out GlycoMimetics's recent earnings performance, and GlycoMimetics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar